Abstract
Purpose of Review
Biobank research brings together participants, their samples and data, and researchers to provide a productive and efficient resource that advances discovery, prevention, diagnosis, and treatment. This mini-review addresses the importance of governance issues regarding consent, privacy and confidentiality, data sharing, and return of results in biobanks that utilize genomic sequencing data.
Recent Findings
With the availability of genomic sequencing data, there is renewed attention to the value of biobank research. Governance components of consent, data sharing, privacy protections, and disclosure of research results vary widely among biobanks currently established. There is no consensus standard of best practice for managing genomic data regardless of the biobank infrastructure.
Summary
Understanding the various biobank research program components will aid genetics providers and other healthcare providers as they interact with biobank researchers and participants. Governance structures for biobanks will need to be informed by the engagement of participants, researchers, and regulatory agencies. Education concerning the importance of biobank research, transparency of governance structure, and the relationship of genomic data to the improvement of individual health is critical to support continued biobank research.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Husedzinovic A, Ose D, Schickhardt C, Fröhling S, Winkler EC. Stakeholders’ perspectives on biobank-based genomic research: systematic review of the literature. Eur J Hum Genet. 2015;23(12):1607–14. https://doi.org/10.1038/ejhg.2015.27.
Bledsoe MJ. Ethical legal and social issues of biobanking: past, present, and future. Biopreserv Biobank. 2017;15:142–7.
Sanderson SC, Brothers KB, Mercaldo ND, Clayton EW, Antommaria AHM, Aufox SA, et al. Public attitudes toward consent and data sharing in biobank research: a large multi-site experimental survey in the US. Am J Hum Genet. 2017;100(3):414–27. https://doi.org/10.1016/j.ajhg.2017.01.021.
Garrison NA, Sathe NA, Antommaria AH, et al. A systematic literature review of individuals’ perspectives on broad consent and data sharing in the United States. Genet Med. 2016;18(7):663–71. https://doi.org/10.1038/gim.2015.138.
Kinkorova J. Biobanks in the era of personalized medicine: objectives, challenges, and innovation: overview. EPMA J. 2016;7:4. https://doi.org/10.1186/s13167-016-0053-7 eCollection 2015.
Vaught J, Lockhart NC. The evolution of biobanking best practices. Clin Chim Acta. 2012;413(19–20):1569–75. https://doi.org/10.1016/j.cca.2012.04.030.
2012 best practices for repositories collection, storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories. Biopreserv Biobank. 2012;10(2):79–161. https://doi.org/10.1089/bio.2012.1022.
Campbell LD, Astrin JJ, DeSouza Y, Giri J, Patel AA, Rawley-Payne M, et al. The 2018 revision of the ISBER best practices: summary of changes and the editorial team’s development process. Biopreserv Biobank. 2018;16(1):3–6. https://doi.org/10.1089/bio.2018.0001.
Rothstein MA, Knoppers BM, Harrell HL. Comparative approaches to biobanks and privacy. J Law Med Ethics. 2016;44(1):161–72. https://doi.org/10.1177/1073110516644207.
Nagai A, Hirata M, Kamatani Y, et al. Overview of the BioBank Japan project: study design and profile. J Epidemiol. 2017;27(3S):S2–8. https://doi.org/10.1016/j.je.2016.12.005.
https://www.decode.com/ Accessed 5.29.2019.
https://www.ukbiobank.ac.uk/ Accessed 5.29.2019.
https://www.geenivaramu.ee/en Accessed 5.29.2019.
https://allofus.nih.gov/about/program-partners/biobank Accessed 5.29.2019.
https://www.geisinger.org/mycode Accessed 5.29.2019.
https://victr.vanderbilt.edu/pub/biovu/ Accessed 5.29.2019.
https://icahn.mssm.edu/research/ipm/programs/biome-biobank Accessed 5.29.2019.
https://www.mayo.edu/research/centers-programs/mayo-clinic-biobank/overview Accessed 5.29.2019.
Abul-Husn NS, Kenny EE. Personalized medicine and the power of electronic health records. Cell. 2019;177(1):58–69. https://doi.org/10.1016/j.cell.2019.02.039.
https://emerge.mc.vanderbilt.edu/. Accessed 5.29.2019.
McCarty CA, Chisholm RL, Chute CG, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011;4:13. Published 2011 Jan 26. https://doi.org/10.1186/1755-8794-4-13.
Gottesman O, Kuivaniemi H, Tromp G, et al. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med. 2013;15(10):761–71. https://doi.org/10.1038/gim.2013.72.
https://www.phekb.org/ Accessed 5.29.2019.
Williams MS, Buchanan AH, Davis FD, et al. Patient-Centered Precision Health in a Learning Health Care System: Geisinger’s Genomic Medicine Experience. Health Affairs. 2018;37(5):757–64. https://doi.org/10.1377/hlthaff.2017.1557 This article addresses the foundations of utilizing implementation science in the context of a learning healthcare system to launch a genomics program that incorporates patient centeredness and principles of iterative evaluation to support ongoing practice improvement.
Chen Z, Chen J, Collins R, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40(6):1652–1666. https://doi.org/10.1093/ije/dyr120.
Dankar FK, Gergely M, Dankar SK. Informed consent in biomedical research. Comput Struct Biotechnol J. 2019;17:463–74. Published 2019 Mar 25. https://doi.org/10.1016/j.csbj.2019.03.010.
Prictor M, Teare HJA, Kaye J. Equitable participation in biobanks: the risks and benefits of a “Dynamic Consent”. Approach Front Public Health. 2018;6:253. Published 2018 Sep 5. https://doi.org/10.3389/fpubh.2018.00253.
Teare HJ, Morrison M, Whitley EA, Kaye J. Towards ‘Engagement 2.0’: Insights from a study of dynamic consent with biobank participants [published correction appears in Digit Health. 2016;2:2055207616628802]. Digit Health. 2015;1:2055207615605644. Published 2015 Sep 28. doi:https://doi.org/10.1177/2055207615605644.
Budin-Ljøsne I, Teare HJ, Kaye J, et al. Dynamic consent: a potential solution to some of the challenges of modern biomedical research. BMC Med Ethics. 2017;18(1):4. Published 2017 Jan 25. https://doi.org/10.1186/s12910-016-0162-9.
Capocasa M, Anagnostou P, D’Abramo F, et al. Samples and data accessibility in research biobanks: an explorative survey. PeerJ. 2016;4:e1613. Published 2016 Feb 25. https://doi.org/10.7717/peerj.1613.
Shi X, Wu X. An overview of human genetic privacy. Ann N Y Acad Sci. 2017;1387(1):61–72. https://doi.org/10.1111/nyas.13211.
Shabani M, Bezuidenhout L, Borry P. Attitudes of research participants and the general public towards genomic data sharing: a systematic literature review. Expert Rev Mol Diagn. 2014;14(8):1053–65. https://doi.org/10.1586/14737159.2014.961917.
McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9(5):356–69. https://doi.org/10.1038/nrg2344.
Hunt LT. The life-changing magic of sharing your data. Nat Hum Behav. 2019;3(4):312–5. https://doi.org/10.1038/s41562-019-0560-3.
Taichman DB, Sahni P, Pinborg A, Peiperl L, Laine C, James A, et al. Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors. JAMA. 2017;317(24):2491–2. https://doi.org/10.1001/jama.2017.6514.
Foster MW, Sharp RR. Share and share alike: deciding how to distribute the scientific and social benefits of genomic data. Nat Rev Genet. 2007;8(8):633–9. https://doi.org/10.1038/nrg2124.
Fischer BA, Zigmond MJ. The essential nature of sharing in science. Sci Eng Ethics. 2010;16:783–99. https://doi.org/10.1007/s11948-010-9239-x.
Harris JR, Burton P, Knoppers BM, Lindpaintner K, Bledsoe M, Brookes AJ, et al. Toward a roadmap in global biobanking for health. Eur J Hum Genet. 2012;20(11):1105–11. https://doi.org/10.1038/ejhg.2012.96.
Yakubu AM, Chen YP, Ensuring privacy and security of genomic data and functionalities. 2019. Brief Bioinform;1–16. doi https://doi.org/10.1093/bib/bbz013.
Frizzo-Barker J, Chow-White PA, Charters A, Ha D. Genomic big data and privacy: challenges and opportunities for precision medicine. Comput Supported Coop Work. 2016. https://doi.org/10.1007/s10606-016-9248-7. Published online 04 March 2016.
Clayton EW, Halverson CM, Sathe NA, Malin BA. A systematic literature review of individuals’ perspectives on privacy and genetic information in the United States. PLoS One. 2018;13(10):e0204417. https://doi.org/10.1371/journal.pone.0204417.
Wolf LE, Patel MJ, Williams Tarver BA, Austin JL, Dame LA, Beskow LM. Certificates of confidentiality: protecting human subject research data in law and practice. J Law Med Ethics. 2015;43(3):594–609. https://doi.org/10.1111/jlme.12302.
Heeney C, Kerr SM. Balancing the local and the universal in maintaining ethical access to a genomics biobank. BMC Med Ethics. 2017;18(1):–80. https://doi.org/10.1186/s12910-017-0240-7 A literature review is presented of policy relevant documents which apply to the conduct of biobanks in two areas: support for open access and the protection of data subjects and researchers managing a bioresource. It discusses limited access to protect privacy, align with participant consent, and ensure that the resource can be managed in a sustainable way.
Middleton A. Society and personal genome data. Hum Mol Genet. 2018;27(R1):R8–R13. https://doi.org/10.1093/hmg/ddy084.
Wolf LE, Brown EF, Kerr R, et al. The Web of Legal Protections for Participants in Genomic Research (February 4, 2019). Health Matrix: Journal of Law-Medicine, Vol. 29, 2019; Georgia State University College of Law, Legal Studies Research pp 2019–07. Available at SSRN: https://ssrn.com/abstract=3328892.
Berkman BE, Miller WK, Grady C. Is it ethical to use genealogy data to solve crimes? Ann Intern Med. 2018;169:333–4. https://doi.org/10.7326/M18-1348.
Norlin L, Fransson MN, Eriksson M, et al. Biopreservation and Biobanking. Aug 2012.ahead of print https://doi.org/10.1089/bio.2012.0003.
Makri E, Ardeshirdavani A, Simm J, et al. Towards practical privacy-preserving genome-wide association study. BMC Bioinf. 2018;19:537. https://doi.org/10.1186/s12859-018-2541-3.
Jarvik GP, Amendola LM, Berg JS, et al. Return of genomic results to research participants: the floor, the ceiling, and the choices in between. American Journal of Human Genetics. 2014;94(6):818–26. https://doi.org/10.1016/j.ajhg.2014.04.009 This is a seminal article laying out considerations for returning genomic sequencing results. The guidance provides a strong foundation for developing a process infrastructure for returning results.
Wolf SM. Return of individual research results and incidental findings: facing the challenges of translational science. Annu Rev Genomics Hum Genet. 2013;14:557–77. https://doi.org/10.1146/annurev-genom-091212-153506.
Thorogood A, Joly Y, Knoppers BM, Nilsson T, Metrakos P, Lazaris A, et al. An implementation framework for the feedback of individual research results and incidental findings in research. BMC Medical Ethics. 2014;15(1). https://doi.org/10.1186/1472-6939-15-88.
Smith LA, Douglas J, Braxton AA, Kramer K. Reporting incidental findings in clinical whole exome sequencing: incorporation of the 2013 ACMG recommendations into current practices of genetic counseling. J Genet Couns. 2014;24(4):654–62. https://doi.org/10.1007/s10897-014-9794-4.
Brett GR, Wilkins EJ, Creed ET, et al. Genetic counseling in the era of genomics: what’s all the fuss about? J Genet Couns. 2018;27:1010–21. https://doi.org/10.1007/s10897-018-0216-x.
Amendola LM, Lautenbach D, Scollon S, Bernhardt B, Biswas S, East K, et al. Illustrative case studies in the return of exome and genome sequencing results. Personalized Medicine. 2015;12(3):283–95. https://doi.org/10.2217/pme14.89.
Jamal SM, Yu J, Chong JX, et al. Practices and policies of clinical exome sequencing providers: analysis and implications. Am J Med Genet A. 2013;161A:935–50. https://doi.org/10.1002/j.1552-4833.2013.35942.x.
Levy KF, Blake K, Fletcher-Hoppe C, et al. Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network. Genetics in Medicine. 2018;21:743–7. https://doi.org/10.1038/s41436-018-0080-y.
Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, et al. Managing incidental findings in human subjects research: analysis and recommendations. The Journal of Law, Medicine & Ethics. 2008;36(2):219–48. https://doi.org/10.1111/j.1748-720X.2008.00266.x.
Parens E, Appelbaum P, Chung W. Incidental findings in the era of whole genome sequencing? Hastings Cent Rep. 2013;43(4):16–99. https://doi.org/10.1002/hast.189.
Brandt DS, Shinkunas L, Hillis SL, Daack-Hirsch SE, Driessnack M, Downing NR, et al. A closer look at the recommended criteria for disclosing genetic results: perspectives of medical genetic specialists, genomic researchers, and institutional review board chairs. J Genet Couns. 2013;22(4):544–53. https://doi.org/10.1007/s10897-013-9583-5.
Stuckey H, Williams JL, Fan AL, Rahm AK, Green J, Feldman L, et al. Enhancing genomic laboratory reports from the patients’ view: a qualitative analysis. Am J Med Genet A. 2015;167A(10):2238–43. https://doi.org/10.1002/ajmg.a.37174.
Williams JL, Rahm AK, Stuckey H, Green J, Feldman L, Zallen DT, et al. Enhancing genomic laboratory reports: a qualitative analysis of provider review. Am J Med Genet A. 2016;170A(5):1134–41. https://doi.org/10.1002/ajmg.a.37573.
Goehringer JM, Bonhag MA, Jones LK, Schmidlen T, Schwartz M, Rahm AK, et al. Generation and implementation of a patient-centered and patient-facing genomic test report in the EHR. EGEMS (Wash DC). 2018;6(1):14. https://doi.org/10.5334/egems.256.
Haga SB, Mills R, Pollak KI, Rehder C, Buchanan AH, Lipkus IM, et al. Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding. Genome Medicine. 2014;6(7):58. https://doi.org/10.1186/s13073-014-0058-6.
Dorschner MO, Amendola LM, Shirts BH, Kiedrowski L, Salama J, Gordon AS, et al. Refining the structure and content of clinical genomic reports. American Journal of Medical Genetics C Seminars in Medical Genetics. 2014 Mar;166C(1):85–92. https://doi.org/10.1002/ajmg.c.31395.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Andrew Faucett reports personal fees as a consultant for The University of Pennsylvania and a grant from Regeneron, outside of submitted work.
Juliann Savatt, Cassandra J. Pisieczko, Yanfei Zhang, Ming Ta Michael Lee, and Janet L. Williams each declare no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Counseling and Testing
Rights and permissions
About this article
Cite this article
Savatt, J., Pisieczko, C.J., Zhang, Y. et al. Biobanks in the Era of Genomic Data. Curr Genet Med Rep 7, 153–161 (2019). https://doi.org/10.1007/s40142-019-00171-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40142-019-00171-w